Now is the time for Food and Drug Administration reforms designed to dramatically increase the number of prescription-to-O-T-C switches in the U.S. At a time when both political parties are pushing for transparency and pricing reform, the opportunity to align multiple agendas that benefit consumers, retail pharmacies and the health care system overall is too
In Dr. Seuss’ (Theodor Geisel’s) last major book, Oh, the Places You’ll Go!, he put forth advice for recent graduates from almost any school: You have brains in your head. You have feet in your shoes. You can steer yourself. Any direction you choose. And you’re on your own. And you know what you know.
There’s never been a more critical time to start turning your shoppers into pharmacy customers. With the 900-pound gorilla, Amazon.com, lurking around the corner ready to pounce on the $500 billion drug industry, drug stores, mass merchants and supermarkets need a plan of action, and they need it now. Amazon has the ability with its
The past year has brought much change, perhaps most evident in the recent national and local elections. As we welcome a new American president and Congress, the country is waiting to see how the regulatory and legislative landscape will evolve. But I am certain that one thing will not change: the continued importance of over-the-counter
NEW YORK — When given a choice in purchasing a prescription or over-the-counter drug, most U.S. consumers will opt for a generic product, a new Harris Poll finds. Harris said Wednesday that of the 2,255 U.S. adults it surveyed, 69% said they would pick the generic drug more often, and 30% indicated that they would